...
首页> 外文期刊>International Journal of Food Microbiology >In vitro and in vivo effect of 2,6-Di-tert-butyl-4-methylphenol as an antibiofilm agent against quorum sensing mediated biofilm formation of Vibrio spp.
【24h】

In vitro and in vivo effect of 2,6-Di-tert-butyl-4-methylphenol as an antibiofilm agent against quorum sensing mediated biofilm formation of Vibrio spp.

机译:体外和体内效应2,6-二叔丁基-4-甲基苯酚作为抗血管传感介导的生物膜形成的抗体SPP的抗血栓药物。

获取原文
获取原文并翻译 | 示例
           

摘要

This study unveils the in vitro and in vivo antibiofihn potential of 2,6-Di-tert-butyl-4-methylphenol (DTBMP) from Chroococcus turgidus against Vibrio spp. In the preliminary study, cell free culture supernatant (CFCS) of C. turgidus inhibited the violacein production in biomarker strain Chromobacterium violaceum and its mutant strain CV026 in a dose dependent manner. The effective biofilm inhibitory concentration (BIC) of pure compound DTBMP from C. turgidus was identified as 250 mu g/ml concentration in tested Vibrio species. Furthermore, DTBMP proved to effectively inhibit the bioluminescence production in V. harveyi and other biofilm related virulence traits such as exopolysaccharides (EPS) production, hydrophobicity index, swimming and swarming motility at its BIC concentration in three major pathogenic vibrios: V. harveyi, V. parahaemolyticus and V. vulnificus. The antibiofilm potential of DTBMP was validated through light, confocal laser scanning and scanning electron microscopic analyses. In addition, the non-bactericidal effect of DTBMP was determined through growth curve and 2,3-bis (2-methyloxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay. Real-time PCR studies revealed the down-regulation of master quorum sensing (QS) regulator genes of V. harveyi such as luxR, luxS, luxP, luxQ and lux on treatment with DTBMP. In vivo results confirmed that DTBMP augmented the survival rate of Litopenaeus vannamei larvae up to 75, 88 and 66% upon infection with V. harveyi, V. parahaemolyticus and V. vulnificus, respectively. The results of this study ascertain the promising effects of DTBMP as an antibiofilm agent, which could be positively explored to treat biofilm-associated vibrios infections in aqua culture.
机译:该研究推出了来自Chroococcus Turgidus的2,6-二叔丁基-4-甲基苯酚(DTBMP)的体外和体内抗体的体内抗性。在初步研究中,C. Turgidus的细胞自由培养上清液(CFCs)抑制了生物标志物菌株浓度紫杉杆菌的紫杉蛋白产生,其突变菌株CV026以剂量依赖性方式。来自C.Cugidus的纯化合物DTBMP的有效生物膜抑制浓度(BIC)鉴定为测试的振动物种中的250μg/ ml浓度。此外,DTBMP证明,在三个主要致病术中,在其BIC浓度下有效地抑制V.Arveyi和其他生物膜相关的毒力特性,如外偶联(EPS)生产,疏水性指数,游泳和蜂拥而至的动力:V.Arveyi,V. 。Parahaemolyticus和V.Vulnificus。通过光,共聚焦激光扫描和扫描电子显微镜分析验证了DTBMP的抗菌潜力。此外,通过生长曲线和2,3-双(2-甲氧基-4-硝基-5-磺基)-2H-四唑-5-羧苄硅(XTT)测定法测定DTBMP的非杀菌作用。实时PCR研究揭示了V. Harveyi的Master Quorum感应(QS)调节器基因的下调,如Luxr,Lux,Luxp,Luxq和Lux与DTBMP处理。体内结果证实,DTBMP分别在患有V.RoTopenaeus Vannamei幼虫的生存率,分别在感染V.RoTopenaeus Vannamei幼虫的存活率,每分别对V. harveyi,V.Parahaemolyticus和V.Vulnificus进行了感染。该研究的结果确定了DTBMP作为抗生素剂的有希望的效果,可以肯定探索治疗水上培养中的生物膜相关的vibrios感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号